Prof. Dr Michael Heuser is a professor of medicine and director of the Department of Internal Medicine, Hematology and Oncology at University Medicine Halle, Germany. He is the chair of the European LeukemiaNet MRD working party ELN-DAVID. His research focuses on developing improved treatments for patients with acute myeloid leukemia (AML), on the pathogenesis of AML, and on measurable residual disease in AML patients. Dr. Heuser has been a clinical investigator in 80 clinical trials and has published 250 peer-reviewed publications.

Dr Vladimir Lazarevic is a Senior consultant at the Department of Hematology, Oncology and Radiation Physics at the Skåne University Hospital in Lund, Sweden and Associate Professor of Hematology at Lund University. He is also a Chairman of the Swedish AML group. Dr Lazarevic has published 61 full-text articles in PubMed and more than 50 abstracts presented at the international meetings.